Bliley Lorillard
Re: Louis A. Soloff, M.D.
Abstract
Reminds Soloff "is most articulate in expressing his views on smoking and health". Indicates his three year National Institutes of Health grant in biochemistry is prestigious and "will supplement Dr. Soloff's [Council for Tobacco Research grant in atherosclerosis] so that he will be able to proceed at an accelerated pace".
Fields
- Company
- Shook, Hardy & Bacon
- Type
- LETTER
- Author
- Hoel, Donald K. (CTR Industry Research Committee & PM Attorney, Shook Hardy)Donald Hoel was an attorney with Philip Morris' law firm Shook Hardy and Bacon (SHB). He served as a member of the CTR Industry Research Committee in 1978?. Hoel assisted in screening "apppropriate" projects to received CTR funding.
- Author (Organization)
- Shook, Hardy & Bacon (Tobacco Industry law firm)Tobacco Industry law firm based in Kansas City, KS.
- Recipient
- Ahrensfeld, Thomas F. (PM General Counsel & Sr. VP, TI Executive Committee)TI Executive committee
- Bryant, DeBaun (CTR Director, BW Attorney)DeBaun Bryant was employed by Brown & Williamson Tobacco Corporation and served as Director for the Council for Tobacco Research 1/31/75, 1/30/76, 1/28/77, 1/27/78 and 1/27/79. He was also a Board Member of the University of Kentucky Tobacco & Health Research Institute in 1979 and 1980.
- Haas, Frederick P. (Liggett, General Counsel)Frederick P. Haas was a member of the Board of Directors of Liggett & Meyers from 1966 through 1976. From 1975 and 76 he was Special Counsel. (N.M., L & M Liability Notebook, Section 3, Personnel List)
- Hetsko, Cyril F. (VP of ATC; CTR Director)Vice President and General Counsel for American Tobacco. Served on the Executive Committee as a CTR Director.
- Roemer, Henry C. (Jack) (RJR VP; CTR Director)RJR in 1958. He served as Vice President & General Counsel of RJR Legal Dept. in 1970, Senior Vice President & General Counsel of their Legal Dept. 1972-1983, and retired in 1986. Board of Directors 1972-1983; as Senior Vice President, General Counsel, and Secretary from 1982 to the present, as RJR Tobacco Secretary & Director 1958-1970; and as Vice President and General Counsel in 1970.
- Stevens, Arthur Joseph (LOR Sr. VP '89-95 and TI Communications)Served on Lorillard Board of Directors 1985-92, was Senior Vice President from 1989 to 1995, served as General Counsel for Lorillard '93-95. Served on Tobacco Institute Communications Committee.
- Copied
- Holtzman, Alexander (PM Asst General Counsel. 1975-85.)
- Pollack, Lester (LOR Exec. VP, Secretary & Gen. Counsel)Employed by Loew's Corp. as Vice President, 1971. Senior Vice President 1972-74, Exec. VP 1975-78. Served on Board of Directors 1971-95, was employed by Loews Theater, Inc.
- Named Person
- Soloff, Louis Alexander, M.D. (Cardiologist, Temple U Health Science Ctr., Industry Expert)Defense
- Named Organization
- National Institutes of Health
- Council for Tobacco Research - USA (CTR) (Formerly Tobacco Industry Research Committee (TIRC))Originally organized as the Tobacco Industry Research Committe(TIRC) in 1954, and renamed Council for Tobacco Research - USA, Inc. (CTR) in 1964.
- Keyword
- Atherosclerosis
- Smoking and Health
- Thesaurus Term
- research activity
- expenditure
- tobacco industry employee
- tobacco industry sponsorship
- cardiovascular system
- tobacco industry structure
- cardiovascular disease
- Cardiovascular Effects (Health Effects)
Document Images
SHOOK,: HARDY ~ BAC;ON
KAN,~A~. CITY, MISSOUII~II f~,4106
August 27, 1973
NUSSEL.~.. $, NOBLET
(;. K[ITt~ LAR$OH
Thomas F. Ahrensfeld, Esq.
DeBaun Bryant, Esq.
Frederick P. Haas, Esq.
Cyril F. Hetsko, Esq.
Henry C. Roemer, Esq.
Arthur J. Stevens, Esq.
Re: Louis A. Soloff, M.D.
Dr. Louis Soloff, as you know, is most articulate in
expressing his views on smoking and health. He is the recip-
ient of a current CTR grant for research on atherosclerosis
and, while NIH may not agree with his views in the smoking
area, he has recently received one of the few National Insti-
tutes of Health grants in biochemistry.
We report this because the grant evidences a recogni-
tion o.f Dr. Soloff and his co-workers as outstanding researchers.
There are presently very few individual NIH grants being awarded
and biochemistry is reported to be one of the most competitive
fields.
The three-year award is not only a reflection of the
importance with which Dr. Soloff's work is viewed, by NIH and
its advisors but will supplement Dr. Soloff's CTR grant so that
he will be able to proceed at an accelerated, pace.
DKH : sh
Ai rmai 1
cc: Alexander Holtzman, Esq.
Lester Pollack, Esq.
Sincerely,
Donald K. Hoel %m
---
